Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
Antimicrob Agents Chemother
; 51(9): 3304-10, 2007 Sep.
Article
en En
| MEDLINE
| ID: mdl-17620371
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Inhibidores de Proteasas
/
Cilastatina
/
Imipenem
/
Infección Hospitalaria
/
Antibacterianos
Tipo de estudio:
Clinical_trials
/
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Antimicrob Agents Chemother
Año:
2007
Tipo del documento:
Article